JPH05504578A - 薬学組成物 - Google Patents

薬学組成物

Info

Publication number
JPH05504578A
JPH05504578A JP3516505A JP51650591A JPH05504578A JP H05504578 A JPH05504578 A JP H05504578A JP 3516505 A JP3516505 A JP 3516505A JP 51650591 A JP51650591 A JP 51650591A JP H05504578 A JPH05504578 A JP H05504578A
Authority
JP
Japan
Prior art keywords
compound
formula
group
substituted
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3516505A
Other languages
English (en)
Japanese (ja)
Inventor
バーロー，リチャード・ボウデン
ヴィール，マーク・アンソニー
Original Assignee
ブリティッシュ・テクノロジー・グループ・リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ブリティッシュ・テクノロジー・グループ・リミテッド filed Critical ブリティッシュ・テクノロジー・グループ・リミテッド
Publication of JPH05504578A publication Critical patent/JPH05504578A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP3516505A 1990-10-23 1991-10-17 薬学組成物 Pending JPH05504578A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9023023.6 1990-10-23
GB909023023A GB9023023D0 (en) 1990-10-23 1990-10-23 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
JPH05504578A true JPH05504578A (ja) 1993-07-15

Family

ID=10684199

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3516505A Pending JPH05504578A (ja) 1990-10-23 1991-10-17 薬学組成物

Country Status (9)

Country Link
EP (1) EP0506903A1 (de)
JP (1) JPH05504578A (de)
AU (1) AU8714991A (de)
CA (1) CA2072598A1 (de)
FI (1) FI922903A (de)
GB (2) GB9023023D0 (de)
PT (1) PT99299A (de)
WO (1) WO1992006958A1 (de)
ZA (1) ZA918381B (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008525359A (ja) * 2004-12-24 2008-07-17 ノバルティス アクチエンゲゼルシャフト Ｍ３アンタゴニストとしての第４級アンモニウム塩類
JP2008529965A (ja) * 2003-06-24 2008-08-07 ノバルティス アクチエンゲゼルシャフト ムスカリン性ｍ３受容体のリガンドとしてのピペリジニウムおよびピロリジニウム誘導体

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7545894A (en) * 1993-09-02 1995-03-22 Yamanouchi Pharmaceutical Co., Ltd. Carbamate derivative and medicine containing the same
NO2005012I1 (no) 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin og farmasoytisk akseptable salter derav
CA2179574A1 (en) * 1995-06-26 1996-12-27 Tomomi Okada Substituted piperidine derivative and medicine comprising the same
PE92198A1 (es) * 1996-08-01 1999-01-09 Banyu Pharma Co Ltd Derivados de 1,4-piperidina disustituida que contienen fluor
EP3233799B1 (de) * 2014-12-19 2021-05-19 The Broad Institute, Inc. Dopamin-d2-rezeptor-liganden
EP3233077A4 (de) 2014-12-19 2018-08-08 The Broad Institute Inc. Dopamin-d2-rezeptor-liganden

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792043A (fr) * 1971-11-30 1973-05-29 Ciba Geigy Derives de la piperidine utilisables pour stabiliser des matieres organiques
IT1231238B (it) * 1987-09-21 1991-11-26 Angeli Inst Spa Derivati ammidinici

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008529965A (ja) * 2003-06-24 2008-08-07 ノバルティス アクチエンゲゼルシャフト ムスカリン性ｍ３受容体のリガンドとしてのピペリジニウムおよびピロリジニウム誘導体
JP2008525359A (ja) * 2004-12-24 2008-07-17 ノバルティス アクチエンゲゼルシャフト Ｍ３アンタゴニストとしての第４級アンモニウム塩類
US8153669B2 (en) 2004-12-24 2012-04-10 Novartis Ag Quaternary ammonium salts as M3 antagonists

Also Published As

Publication number Publication date
AU8714991A (en) 1992-05-20
GB9122083D0 (en) 1991-11-27
EP0506903A1 (de) 1992-10-07
WO1992006958A1 (en) 1992-04-30
CA2072598A1 (en) 1992-04-24
GB2249093A (en) 1992-04-29
ZA918381B (en) 1993-04-21
GB9023023D0 (en) 1990-12-05
FI922903A0 (fi) 1992-06-22
FI922903A (fi) 1992-06-22
PT99299A (pt) 1992-08-31

Similar Documents

Publication Publication Date Title
JP5524939B2 (ja) 胃腸疾患および中枢神経系疾患の治療のための立体異性体化合物と方法
IE920750A1 (en) New imidazopyridines as serotonergic 5-ht3 antagonists
JPS6049192B2 (ja) 新規置換ベンズアミド、その製造方法及びこれを有効成分とする向精神薬
JPS61183223A (ja) アリールアミドアザビシクロアルカンを含む記憶増強または記憶欠損矯正用組成物
JPH06510537A (ja) ５−ｈｔ４レセプター・アンタゴニスト
TW200808807A (en) Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
UA47396C2 (uk) N-заміщені азагетероциклічні карбонові кислоти та їх ефіри, спосіб їх одержання та фармацевтична композиція на їх основі (варіанти), спосіб її одержання та спосіб лікування нейрогенного запалення
JPH01226818A (ja) アリールアミドアザビシクロアルカン類およびアリールチオアミドアザビシクロアルカン類からなる記憶力増進剤または記憶障害治療剤
JPH03173867A (ja) 環状アミン化合物
EP2411368A1 (de) Nicotinamidderivate, deren herstellung und deren therapeutische verwendung als antikrebsmittel
HUE032761T2 (en) Process for the preparation of piperazinyl and diazepanylbenzamide derivatives
JP2502343B2 (ja) 薬学的に活性な置換ベンズアミド
DE69012650T2 (de) Piperidinderivat, Verfahren zur Herstellung davon und dieses enthaltende pharmazeutische Zusammensetzung.
AU740662B2 (en) 1,4-disubstituted piperazines
JPH05504578A (ja) 薬学組成物
JPH05117268A (ja) ピリジン化合物
JPS6055068B2 (ja) １−（３−ハロ−２−ピリジニル）ピペラジン
SK9398A3 (en) (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2- -methoxy-6-methylamino-3-pyridine-carboxamide, process for producing the same and medicinal composition containing the same
DE69523595T2 (de) Aryl und heteroaryl alkoxynaphtalen derivate
US2914533A (en) Tertiary-aminoalkyl n-(pyridyl)carbamates and their preparation
JPS5888369A (ja) 新規な４−フエニルキナゾリン誘導体、その製法及びその医薬品としての利用
KR100437561B1 (ko) 신규헤테로고리화합물
NZ242305A (en) Pyrido-,pyrrolo-,thieno- and dibenzo-diazepine derivatives; preparatory processes and pharmaceutical compositions
GB2162843A (en) Piperazine derivatives
US5180726A (en) 4-[4- or 6-(trifluoromethyl-2-pyridinyl)]-1-piperazinylalkyl substituted lactams